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Summary and Conclusions
Probiotic cultures are described as live microbial feed supplements that
improve intestinal microbial balance and are intended for maintenance of
health or prevention, rather than the curing of disease.  The demand for
probiotic foods is increasing in Europe, Japan and the U.S. reflecting the
heightened awareness among the public of the relationship between diet
and health.  
Traditionally, the most popular food delivery systems for these cultures have
been freshly fermented dairy foods, such as yogurts and fermented milks, as
well as unfermented milks with cultures added.  However, in the
development of functional foods, the technological suitability of probiotic
strains poses a serious challenge since their survival and viability may be
adversely affected by processing conditions as well as by the product
environment and storage conditions.  This is a particular concern, given that
high levels  (at least 107 per gram or ml) of live micro-organisms are
recommended for probiotic products. 
In previous studies (see DPRC No. 29) the successful manufacture of
probiotic Cheddar cheese harbouring high levels (>108 cfu/g) of the
probiotic Lactobacillus paracasei NFBC 338 strain was reported.
Hence, the overall objective of these studies was to continue the
development and evaluation of Functional Foods containing high levels of
viable probiotic bacteria, with particular emphasis on overcoming the
technological barriers and the identification of strains suited to particular
applications, such as incorporation into Cheddar cheese and spray-dried
powders.
The Main Conclusions were as follows:
These studies demonstrate that probiotic strains and their key beneficial
traits can withstand the technological stresses involved in the manufacture of
Cheddar cheese and spray-dried powders.
3
Probiotic Cheddar: 
*  A probiotic Cheddar cheese containing high numbers of probiotic Lb.
paracasei NFBC 338 was manufactured at pilot scale before being
successfully scaled up to commercial cheese plant production level.  
* Sensory evaluation of the cheese by experienced commercial cheese
graders indicated that the cheese was not adversely affected by the presence
of the probiotic strain.
*  The probiotic counts remained high (> 108 cfu/g) throughout the six-
month maturation period and the cheese proved a good carrier of the
probiotic strain to the intestine in model trials using pigs.
* A probiotic Cheddar cheese, harbouring large numbers of bifidobacteria
was also manufactured successfully at pilot-scale, exhibiting improved
Cheddar flavour during early ripening.
Probiotic Spray-Dried Powders:
* Spray drying of skim milk was evaluated as a means of preservation of Lb.
paracasei NFBC 338 and Lb. salivarius UCC 118. It was demonstrated that
Lb. paracasei NFBC 338 is more heat resistant than Lb. salivarius UCC 118
and exhibits superior survival during spray drying. Both spray-dried cultures
appeared stressed following spray drying. 
*  The heat tolerance and survival of probiotic lactobacilli during spray
drying was significantly improved by tempering of the cultures with mild
heat or salt.
*  The survival of both Lactobacillus strains during powder storage was
inversely related to storage temperature.  Maximum survival was achieved
at 4ºC. 
*  Probiotic spray-dried powder containing Lb. paracasei NFBC 338 was an
effective inoculum, as an adjunct for probiotic Cheddar cheese, without
adversely affecting product quality.
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Technique Development:
*  A technique was developed using LIVE/DEAD® BacLight Viability Kit
in conjunction with Confocal Scanning Laser Microscopy (CSLM) to
enumerate viable bacteria in situ in probiotic dairy products.
*  RAPD PCR was found to be a useful method for discriminating between
different bifidobacteria species and for confirmation of the identity of
particular bifidobacteria strains in dairy products.
Research and Results 
Probiotic Strain Selection and Detection
To incorporate bifidobacteria into Cheddar cheese, a high inoculum (109
cells/ml inoculum approx.) is necessary. Therefore, initially, effort was
devoted to the generation of concentrated cultures of selected human
isolates.  
Growth curves of bifidobacteria in various media including:
- TPY 
- 10% reconstituted skim milk (RSM) supplemented with 0.5% yeast
extract,  and 
- MRS supplemented with 0.05% cysteine hydrochloride were 
performed.
Consequently, MRS supplemented with 0.05% cysteine hydrochloride was
chosen as the most effective medium for yielding high cell numbers (109
cells/ml) and growth of bifidobacteria strain UCC 35612 in a 5 L laboratory
scale fermentor.
It was demonstrated that RAPD PCR may be a useful method for
discriminating between different bifidobacteria species and for confirmation
of the identity of particular bifidobacteria strains in dairy products.  A
selective medium was developed for bifidobacteria which allows for
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discrimination of bifidobacteria from other microflora in food products,
including lactobacilli, streptococci and E.coli.  
Using this medium, retail 'probiotic' yogurts were found to contain from 105
to 107 viable bifidobacteria/ml of product, indicating that a number of so-
called 'probiotic' products do not meet the minimum recommended level of
107 probiotic cells/ml. 
Probiotic dairy products were examined microscopically, using Confocal
Scanning Laser Microscopy (CSLM), with the LIVE/DEAD® BacLight™
Viability Kit (Fig. 1). 
The LIVE/DEAD® BacLight™ Viability Kit  (Molecular Probes Inc.,  Eugene,
OR, USA) was developed to differentiate live and dead bacteria based on
plasma membrane permeability and has been used to monitor growth of
bacterial populations.  The Viability Kit comprises two fluorescent nucleic
acid stains: SYTO 9 and propidium iodide (PI). SYTO 9
(excitation/emission maxima 480/500 nm) penetrates both viable and non-
viable bacteria while PI (excitation/emission maxima 490/635 nm)
penetrates bacteria with damaged plasma membranes, thereby quenching
the green SYTO 9 fluorescence.  Bacterial cells with compromised
membranes thus fluoresce red and those with intact membranes fluoresce
green. 
All microscopy work was performed using a Zeiss LSM310 confocal
scanning laser microscope (Carl Zeiss Ltd, Welwyn Garden City, Herts., UK)
using the method involving the LIVE/DEAD® BacLight™ viability staining
kit. The sensitivity of the in situ viability staining technique was established
by direct comparison of the bacterial numbers obtained in an actively
growing broth culture obtained by plate counting, and CSLM.  In situ
LIVE/DEAD® BacLight™ bacterial viability staining in conjunction with
CSLM was then compared with Standard Plate Counts for enumeration and
viability assessment of probiotic bacteria in a range of dairy products
including Cheddar cheese and spray-dried powders.  
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Probiotic Cheese Using Commercial Bifidobacteria Strains
Commercial strains of bifidobacteria (Bifidobacterium lactis Bb-12 and
Bifidobacterium longum Bb 536) were used in the manufacture of probiotic
cheeses.  Two vats of Cheddar cheese were manufactured at pilot-scale,
each with a different adjunct of the commercial probiotic bifidobacterial
strains and their viability throughout ripening investigated in addition to
Cheddar composition.  The bifidobacteria were added during Cheddar
cheese manufacture at levels of 108 cfu/ml of cheesemilk.  
One (Bifidobacterium lactis Bb-12) survived ripening to high numbers (≥
108 cfu/g), while viability of the other strain was reduced to 105 cfu/g cheese
after one month of ripening.  
The Cheddar cheese, in which the probiotic bifidobacterial strain survived
to high numbers was examined microscopically, using CSLM and the
probiotic bifidobacteria were identified in the cheese using the
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Fig. 1:  LIVE/DEAD® BacLight viability staining and CSLM.
Control Cheese                   Probiotic Cheese
LIVE/DEAD® BacLight™ Viability Kit (Fig. 1).  The cheeses were analysed
for composition and were generally found to be within normal limits.
The probiotic cheese containing 108 cfu/g cheese was found to have more
extensive proteolysis and improved flavour in the early stages of ripening
than the control cheese containing no added probiotic strain.  Gas
Chromatography Mass Spectroscopy of extracts of volatile compounds
showed differences between the cheese containing the surviving probiotic
strain compared with the control cheese. 
Cheese-making trials with Lb. paracasei NFBC 338
The level of probiotic ingestion believed to be required by human subjects
during feeding trials is in the order of 1010 cfu/day of the probiotic strain, a
level equivalent to ingestion of 20 - 40 g of cheese containing 2.5 - 5 x 108
cfu/g per day.  Although no guidelines exist in Europe at this time, current
Japanese guidelines recommend that a probiotic food should contain at
least 107 cells per g or ml of product.  Hence the objective was to develop
and manufacture sufficient quantities of probiotic Cheddar cheese
harbouring high numbers of Lb. paracasei NFBC 338 suitable for human
clinical evaluation.
Mini cheese trials were performed to assess whether starter combinations
used during Cheddar cheese manufacture had an effect on probiotic
numbers in the cheese curd.  The following starter combinations were used
in conjunction with probiotic Lb. paracasei NFBC 338 as adjunct, to mimic
probiotic Cheddar cheese manufacture, under a variety of possible
commercial applications: i.e. Lactococcus lactis subsp. cremoris 303 and
227, Lactococcus lactis subsp. cremoris 223 and 227, and Lactococcus
lactis subsp. cremoris R604.  
No effects on probiotic Lb. paracasei NFBC 338 levels in the curd were
obtained, as a result of employing the various combinations of starter
cultures during manufacture.  The cheesemilk was inoculated with probiotic
adjunct at 3.9 x 106 cfu/ml, resulting in levels in the curd of 5.0 - 7.5 x 107
cfu/g, irrespective of starter combination. 
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Subsequently, pilot-scale trials were performed which were aimed at
identifying the minimum inoculum of the probiotic that would result in
Cheddar cheese harbouring ≥108 cfu/g.  As a result, it was confirmed that
inocula of 1% (w/v) or higher were sufficient to yield probiotic counts in the
cheese of > 108 cfu/g. Lb. paracasei NFBC 338 numbers in one-day-old
cheeses as a result of using 1 and 2% inocula of the adjunct probiotic culture
during manufacture were 0.9 x 108 and 1.2 x 108 cfu/g, respectively which
increased to 3.5 x 108 cfu/g after one month of ripening at 8ºC. 
Having identified maximum numbers to which the probiotic strain grew (3.5
x 108 cfu/g), probiotic Cheddar cheese (180 kg) was manufactured at pilot-
scale for clinical evaluation.  The adjunct (2% inoculum of Lb. paracasei
NFBC 338) was incorporated with the cheese starters Lactococcus lactis
subsp. cremoris 227 and 303 at 1.4%, while control cheese was
manufactured using the same standardised milk as used for the probiotic
cheese but without the addition of the starter adjunct.  Probiotic counts in
cheese reached 3.0 x 108 cfu/g after one month of ripening at 8ºC.  
Compositions of the control and probiotic cheeses were in the range typical
for Cheddar, and the cheeses were classified as commercial grade with
respect to sensory criteria for both flavour and texture, with the probiotic
cheese scoring slightly higher. These results confirm that Cheddar cheese is
capable of harbouring high numbers of Lb. paracasei NFBC 338 and is also
a suitable matrix for growth of the probiotic strain without adversely altering
Cheddar cheese characteristics. 
Finally, Cheddar cheese manufacturing trials were undertaken at a scale
similar to that employed in industry to demonstrate the viability of Lb.
paracasei NFBC 338 at industrial scale.  In the first such trial, the probiotic
adjunct culture was introduced into the cheese milk in 10% (w/v) RSM
containing 0.5% (w/v) yeast extract.  The yeast extract was prepared in an
industrial pilot scale fermentor at 37ºC for 24 hours, with  the pH
maintained constant at 6.5 throughout the fermentation by the addition of
a concentrated solution of NaOH, using a pH stat.  Cheddar cheese was
manufactured in a 3000 L OST 4 vat using a 1% inoculum of the overnight
culture of Lb. paracasei NFBC 338, which contained 1.1 x 109 cfu/ml.  
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Subsequently, the probiotic strain was present at a level of 2.0 x 108 in one-
day-old cheese, which increased to 3.5 x 108 cfu/g after two week of
ripening at 8ºC, and were at 6.0 x 108 after three months of ripening. 
Commercial cheese manufacturing trials were undertaken in 22,000 litre
vats in a commercial cheese manufacturing plant.  On the day before
probiotic cheese manufacture, the use of lactobacilli as adjuncts to the
starters was avoided in the plant. This was done so that enumeration of the
probiotic Lactobacillus strain in the cheese could be easily performed
(without interference from other lactobacilli), using only selective media for
enumeration of the probiotic strain. The inoculum for this commercial trial
was initially grown in 100 litres MRS inoculated (at 10% v/v) into a bulk
starter tank (1000 litres) containing pasteurised RSM (12.5% w/v) with
0.5% (w/v) yeast extract and incubated at 37ºC for ~20 hours.  Probiotic
counts after 20 hours of growth in RSM were 6.1 x 108 cfu/ml.  This was
used to innoculate the 22,000 litre vats at a rate of 0.1%.  In all, the
probiotic Lb. paracasei NFBC 338 was added to 15 vats as an adjunct to
the starter for probiotic cheese manufacture with one vat used as the control
(to which no probiotic Lactobacillus adjunct was added).  Probiotic counts
in the cheese milk were 3.1 x 106 cfu/ml.  Following one week of ripening
at 8ºC, Lactobacillus counts in the probiotic cheese were 5.0 x 108 cfu/g,
and remained high following one month of ripening (4.3 x 108 cfu/g).
RAPD PCR was used to confirm the identity of the probiotic strain in the
cheese, and counts remained stable throughout ripening for 6 months.  
Sensory grading of the probiotic cheese was performed by commercial
graders.  The flavour of the probiotic cheese was compared with the control,
throughout ripening, and was described as mature, with a sharp flavour at
6 months.  A randomised, double blind, placebo-controlled clinical feeding
study using healthy human subjects has been undertaken and the effects of
ingestion of the probiotic cheese on various health parameters have been
established.
In a separate study, the probiotic Lactobacillus culture was introduced into
the cheese milk in the form of a spray-dried probiotic powder.  Lb. paracasei
NFBC 338 (RifR®) was spray dried in a tall-form, Niro spray drier and
contained 1 x 109 cfu/g powder. This was incorporated during Cheddar
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cheese manufacture in the cheesemilk at 0.1% (w/v) inoculum.  The
probiotic strain grew in the cheese during ripening at 8ºC to reach levels of
1.3 x 108 cfu/g after one month.  However, the probiotic had decreased to
7.7 x 107 cfu/g after 3 months of ripening. 
This experiment demonstrated that adding a relatively low inoculum of the
probiotic culture in spray-dried powder form (0.1% w/v) to the cheese vat
at manufacture yielded Cheddar cheese which falls within the guidelines
proposed for probiotic foods, i.e. containing at least 107 viable probiotic
cells per gram or ml.   Both the composition and sensory properties of this
probiotic cheese were unaffected by the culture introduced in this way.
Cheddar cheese incorporating Lactobacillus salivarius UCC 118 (RifR®)
was also manufactured at pilot scale (450 L).  This probiotic strain was
incorporated at an inoculum of 1.6 x 106 cfu/ml and was present in one-
day-old cheese at a level of 1.2 x 107 cfu/g.  Following one month of
ripening, the probiotic count has decreased to 7.1 x 106 cfu/g cheese.
Therefore, this cheese cannot be described as 'probiotic', using current
guidelines.
Pig Feeding Trials
It was confirmed that the process of cheese-making did not affect the ability
of the probiotic Lb. paracasei NFBC 338 culture to survive in the intestine
and colonise intestinal epithelium through a feeding trial (lasting 3 weeks)
involving the porcine model fed the strain in Cheddar cheese, containing
high levels (~108 cfu/g) of the rifampicin resistant variant of Lb.  paracasei
NFBC 338.
The probiotic strain was detected in faecal samples of probiotic-fed pigs
during the feeding trial at levels of ~106 cfu/g, and the probiotic strain was
not present in faecal samples from control pigs.  This result demonstrated
that the strain in Cheddar cheese survived passage through the mammalian
GIT.  Furthermore, the probiotic strain was detected in the small intestinal
contents of the probiotic-fed animals (at levels of 104 - 105 cfu/ml) and not
in intestinal contents of pigs fed the control cheese, at the end of the 3-week 
feeding period.
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Spray-Dried Milk Powders containing Live Probiotic Bacteria
Spray drying of skim milk was evaluated as a means of preservation of Lb.
paracasei NFBC 338 and Lb. salivarius UCC 118.  It was demonstrated that
Lb. paracasei NFBC 338 is more heat resistant than Lb. salivarius UCC 118
and exhibits superior survival during spray drying. An air outlet temperature
of 80 - 85ºC was optimal for spray drying, yielding powders with a moisture
content of 4.1 - 4.2% and viable counts of 3.2 x 109 cfu/g Lb. paracasei
NFBC 338 and 5.2 x 107 cfu/g Lb. salivarius UCC 118.  Thus, Lb. paracasei
NFBC 338 exhibited superior survival during spray drying compared with
Lb. salivarius UCC 118. Both spray-dried cultures appeared stressed
following spray drying, as evidenced by increased sensitivity of these
cultures to NaCl.  
Nonetheless, cellular activities such as bacteriocin production were
unaffected by the spray drying process.  Maximum survival of probiotic
lactobacilli in the spray-dried powders was achieved by storage at 4ºC, and
survival of both Lactobacillus strains were inversely related to powder
storage temperature.  Survival of Lb. paracasei NFBC 338 remained
constant at levels of ~1 x 109 cfu/g during 2 months of powder storage at
4ºC while a decline of approximately one log (from 7.2 x 107 to 9.5 x 106
cfu/g) was observed for Lb. salivarius UCC 118 stored under the same
conditions.  
A number of approaches have been examined with a view to improving
culture viability during spray drying, a process which costs up to six times
less per kg of water removed than freeze drying.  One such approach
involves the exploitation of microbial stress responses. We examined the
increased degree of thermotolerance and suitability for spray drying
conferred on probiotic Lb. paracasei NFBC 338 by adaptation to different
stresses, such as heat, hydrogen peroxide and salt.  Heat-adapted cells
induced homologous tolerance and cross protection against NaCl, bile-salt
toxicity and cold storage. Although not as efficient as the homologous stress,
the levels of cross protection were in the order heat  ~ salt > hydrogen
peroxide > bile.  Viability of the heat-adapted Lb. paracasei NFBC 338 in
RSM was enhanced 18-fold during spray drying at outlet temperatures of 95
to 105ºC, while salt-adapted cultures exhibited 16-fold greater viability than
controls (Fig. 2). 
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These data highlight the effectiveness of pre-conditioning treatments of
probiotic strains on the optimisation of viability during the harsh conditions
encountered during the manufacture of spray-dried powders.  
This approach offers potential for maximizing survival of probiotic bacteria
during development of probiotic functional foods.  The cross-protection
afforded by salt against thermal stress may indicate  that  certain common
protective proteins are induced in the cell by both heat and salt stress
(Fig. 3).
Influence of Spray Drying on Probiotic Properties 
The effect of spray drying on the capability of the probiotic bacterial strain
Lb. paracasei NFBC 338 to adhere to gut epithelial tissue was assessed.
Adherence of probiotics to epithelial cells in culture is used as an  indicator
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Fig. 2:  Pre-adaption improves survival of Lb. paracasei NFBC 338 during spray drying.
of their ability to colonise the gastrointestinal tract.  HT-29 cells are human
intestinal cell-lines expressing morphological and physiological
characteristics of normal human enterocytes.  This cell-line has been
previously exploited to elucidate the mechanisms mediating
enteropathogen adhesion and have been employed in order to select for,
and subsequently assess lactic acid bacteria on the basis of their adherence
properties. In this study, the ability of Lb. paracasei NFBC 338 to adhere to
HT-29 monolayers was assessed following spray drying of the bacterial
culture.  Re-suspended spray-dried powder (containing 8.2 x 108 cfu/g of
Lb. paracasei NFBC 338) was added to the eucaryotic cells, and following
incubation at 37ºC, approx. 8.0 x 104 adherent lactobacilli were recovered
using conventional microbiology techniques.  
This result  indicates that the ability of the probiotic bacterial strain to adhere
to intestinal epithelial cells was not impaired by the process of spray drying.  
For further information, please contact 
Dr. Catherine Stanton or Dr. R.P. Ross
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Fig. 3:  Proteomic approach to identify stress proteins in Lb. paracasei NFBC 338.
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